Published in Managed Care Law Weekly, December 31st, 2006
This trend article about Federal University of Minas Gerais, Brazil, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A new study, "Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alphabeta and gammadelta T cells from human patients with cutaneous leishmaniasis," is now available. According to a study from Bahia, Brazil, "Although most T lymphocytes express the alphabeta T-cell receptor and either CD4 or CD8 molecules, a small population of cells lacking these coreceptors, CD4-CD8-(double negative [DN]) T cells, has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.